Compare BBNX & FDUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BBNX | FDUS |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | United States | United States |
| Employees | 423 | N/A |
| Industry | Medical/Dental Instruments | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 493.1M | 683.6M |
| IPO Year | N/A | 2011 |
| Metric | BBNX | FDUS |
|---|---|---|
| Price | $10.37 | $17.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $26.22 | $21.17 |
| AVG Volume (30 Days) | ★ 1.1M | 263.5K |
| Earning Date | 01-01-0001 | 05-29-2026 |
| Dividend Yield | N/A | ★ 11.99% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.08 |
| Revenue | N/A | N/A |
| Revenue This Year | $34.99 | $6.01 |
| Revenue Next Year | $34.47 | $4.28 |
| P/E Ratio | ★ N/A | $8.54 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.89 | $17.41 |
| 52 Week High | $32.71 | $22.09 |
| Indicator | BBNX | FDUS |
|---|---|---|
| Relative Strength Index (RSI) | 25.83 | 38.18 |
| Support Level | N/A | $17.41 |
| Resistance Level | $15.53 | $20.58 |
| Average True Range (ATR) | 0.67 | 0.48 |
| MACD | 0.08 | -0.01 |
| Stochastic Oscillator | 11.22 | 23.68 |
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
Fidus Investment Corp is an externally managed, closed-end, non-diversified management investment company that has elected to be treated as a business development company. The company provides customized debt and equity financing solutions to lower middle-market companies. Its investment objective is to provide attractive risk-adjusted returns by generating both current income from debt investments and capital appreciation from equity related investments. The company's portfolio of investment is comprised of securities of companies from different industries such as, Information Technology Services, Business Services, Healthcare Products among others.